Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$13.89 - $15.04 $860,568 - $931,818
61,956 New
61,956 $860,000
Q4 2022

Jan 10, 2023

SELL
$12.42 - $15.62 $310,500 - $390,500
-25,000 Reduced 55.56%
20,000 $312,000
Q3 2022

Oct 19, 2022

BUY
$12.8 - $28.65 $576,000 - $1.29 Million
45,000 New
45,000 $583,000
Q1 2022

Apr 25, 2022

SELL
$13.54 - $15.35 $2.3 Million - $2.6 Million
-169,500 Closed
0 $0
Q4 2021

Jan 10, 2022

SELL
$13.17 - $16.4 $1.6 Million - $1.99 Million
-121,253 Reduced 41.7%
169,500 $2.31 Million
Q3 2021

Oct 13, 2021

BUY
$16.3 - $17.26 $2.06 Million - $2.18 Million
126,143 Added 76.63%
290,753 $4.76 Million
Q2 2021

Jul 14, 2021

BUY
$16.55 - $18.64 $1.02 Million - $1.15 Million
61,622 Added 59.83%
164,610 $2.77 Million
Q1 2021

Apr 12, 2021

BUY
$16.71 - $19.9 $1.72 Million - $2.05 Million
102,988 New
102,988 $1.88 Million
Q4 2020

Jan 19, 2021

SELL
$15.39 - $18.97 $787,968 - $971,264
-51,200 Closed
0 $0
Q3 2020

Oct 09, 2020

BUY
$17.1 - $19.19 $875,520 - $982,528
51,200 New
51,200 $913,000
Q2 2020

Jul 10, 2020

SELL
$14.59 - $19.5 $262,620 - $351,000
-18,000 Closed
0 $0
Q1 2020

Apr 09, 2020

BUY
$13.02 - $20.31 $234,360 - $365,580
18,000 New
18,000 $273,000
Q4 2019

Jan 10, 2020

SELL
$16.88 - $20.83 $16 - $20
-1 Closed
0 $0
Q3 2019

Oct 25, 2019

SELL
$16.15 - $17.99 $35,513 - $39,560
-2,199 Reduced 99.95%
1 $0
Q2 2019

Jul 24, 2019

SELL
$16.58 - $20.49 $1.36 Million - $1.68 Million
-81,946 Reduced 97.39%
2,200 $38,000
Q1 2019

Apr 17, 2019

SELL
$16.7 - $21.52 $1.04 Million - $1.33 Million
-62,010 Reduced 42.43%
84,146 $1.71 Million
Q3 2018

Oct 29, 2018

BUY
$19.54 - $21.81 $1.11 Million - $1.23 Million
56,556 Added 63.12%
146,156 $3.12 Million
Q2 2018

Jul 18, 2018

BUY
$18.98 - $24.95 $1.7 Million - $2.24 Million
89,600 New
89,600 $1.87 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $46B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.